Intellectual Property

We are maximizing our intellectual property rights by effectively aligning and integrating our business and intellectual property management strategies. To help us do this, we are building a patent portfolio for the protection of our therapeutic agents resulting from our Pyramid™ drug discovery platform and collaborations.

Astex Pharmaceuticals™ currently owns a significant portfolio of patent families covering small molecules and their uses in a variety of therapeutic areas, including inhibitors of CDK, PKB, FGFr, Hsp90, XIAP, and tyrosine kinase.

Astex Pharmaceuticals has protection in our considerable know how and trade secrets for the Pyramid™ platform and other proprietary technologies and information.

The logos shown below and Pyramid™, AutoSolve, AstexViewer, HTX and Astex Rule of 3 are trademarks and, in some cases, registered trademarks of Astex Pharmaceuticals in various countries.